These institutions have an awesome power that no mortal could dream of:
The power to print money. Trillions of dollars – on-demand.
..For the first time in history - central banks are now funneling trillions of dollars, directly into the stock market.
The Swiss National Bank is on a buying spree – adding hundreds of thousands of shares of Ford, Xcel Energy, Costco, and many other American companies to its portfolio in the last few months.
According to Bloomberg, The Bank of Japan is now the #1 buyer of Japanese stocks. And if their buying binge continues – within a few years, they could own the ENTIRE market! China's Central bank – the world's largest central bank, worth more than $5.4 trillion -- is now a Top 10 shareholder in the biggest, most well-known stocks in Shanghai.
Goldman Sachs defines regenerative medicine as approaches that grow cells or tissue from stem cells, treatments that promote regeneration, or transplants using organs or tissue grown outside the body.
Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
..$20 billion in mergers and acquisitionsin the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine. ..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
..We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.
Market Data 
Markets 
AI
